93 related articles for article (PubMed ID: 15178343)
1. Hypoxia-dependent regulation of PHD1: cloning and characterization of the human PHD1/EGLN2 gene promoter.
Erez N; Stambolsky P; Shats I; Milyavsky M; Kachko T; Rotter V
FEBS Lett; 2004 Jun; 567(2-3):311-5. PubMed ID: 15178343
[TBL] [Abstract][Full Text] [Related]
2. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT.
Zelzer E; Levy Y; Kahana C; Shilo BZ; Rubinstein M; Cohen B
EMBO J; 1998 Sep; 17(17):5085-94. PubMed ID: 9724644
[TBL] [Abstract][Full Text] [Related]
3. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia.
Salceda S; Beck I; Caro J
Arch Biochem Biophys; 1996 Oct; 334(2):389-94. PubMed ID: 8900415
[TBL] [Abstract][Full Text] [Related]
4. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
5. Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism.
Wellmann S; Bührer C; Moderegger E; Zelmer A; Kirschner R; Koehne P; Fujita J; Seeger K
J Cell Sci; 2004 Apr; 117(Pt 9):1785-94. PubMed ID: 15075239
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factors in the first trimester human lung.
Groenman F; Rutter M; Caniggia I; Tibboel D; Post M
J Histochem Cytochem; 2007 Apr; 55(4):355-63. PubMed ID: 17189520
[TBL] [Abstract][Full Text] [Related]
7. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
Seifert A; Katschinski DM; Tonack S; Fischer B; Navarrete Santos A
Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element.
Metzen E; Stiehl DP; Doege K; Marxsen JH; Hellwig-Bürgel T; Jelkmann W
Biochem J; 2005 May; 387(Pt 3):711-7. PubMed ID: 15563275
[TBL] [Abstract][Full Text] [Related]
9. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
Peurala E; Koivunen P; Bloigu R; Haapasaari KM; Jukkola-Vuorinen A
Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
[TBL] [Abstract][Full Text] [Related]
10. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.
Erez N; Milyavsky M; Eilam R; Shats I; Goldfinger N; Rotter V
Cancer Res; 2003 Dec; 63(24):8777-83. PubMed ID: 14695194
[TBL] [Abstract][Full Text] [Related]
11. A conserved family of prolyl-4-hydroxylases that modify HIF.
Bruick RK; McKnight SL
Science; 2001 Nov; 294(5545):1337-40. PubMed ID: 11598268
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
Huang KT; Mikeska T; Dobrovic A; Fox SB
Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
14. Role of the intracellular localization of HIF-prolyl hydroxylases.
Yasumoto K; Kowata Y; Yoshida A; Torii S; Sogawa K
Biochim Biophys Acta; 2009 May; 1793(5):792-7. PubMed ID: 19339211
[TBL] [Abstract][Full Text] [Related]
15. Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors.
Rowlands JC; McEwan IJ; Gustafsson JA
Mol Pharmacol; 1996 Sep; 50(3):538-48. PubMed ID: 8794892
[TBL] [Abstract][Full Text] [Related]
16. Role of CBP in regulating HIF-1-mediated activation of transcription.
Ruas JL; Poellinger L; Pereira T
J Cell Sci; 2005 Jan; 118(Pt 2):301-11. PubMed ID: 15615775
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization and regulation of hypoxia-inducible factor-2alpha in vascular endothelial cells.
Takahashi R; Kobayashi C; Kondo Y; Nakatani Y; Kudo I; Kunimoto M; Imura N; Hara S
Biochem Biophys Res Commun; 2004 Apr; 317(1):84-91. PubMed ID: 15047151
[TBL] [Abstract][Full Text] [Related]
18. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
19. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression.
Sato F; Bhawal UK; Kawamoto T; Fujimoto K; Imaizumi T; Imanaka T; Kondo J; Koyanagi S; Noshiro M; Yoshida H; Kusumi T; Kato Y; Kijima H
Genes Cells; 2008 Feb; 13(2):131-44. PubMed ID: 18233956
[TBL] [Abstract][Full Text] [Related]
20. Binding and regulation of hypoxia-inducible factor-1 by the inhibitory PAS proteins.
Jang MS; Park JE; Lee JA; Park SG; Myung PK; Lee DH; Park BC; Cho S
Biochem Biophys Res Commun; 2005 Nov; 337(1):209-15. PubMed ID: 16182248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
